CLINICAL RELEVANCE: DRUG–DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS, AND TOXICITY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 841

375. Seitz S, Kretz-Rommel A, Oude Elferink RP, Boelsterli UA. 1998. Selective protein
adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular
conjugate export pump (Mrp2). Chem Res Toxicol 11: 513-519.
376. Sasaki M, Suzuki H, Ito K, Abe T, Sugiyama Y. 2002. Transcellular transport of or-
ganic anions across a double-transfected Madin-Darby canine kidney II cell monolayer
expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and
multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 277: 6497-
6503.
377. Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, Sugiyama Y. 2001. Char-
acterization of bile acid transport mediated by multidrug resistance associated protein 2
and bile salt export pump. Biochim Biophys Acta 1511: 7-16.
378. Horikawa M, Kato Y, Tyson CA, Sugiyama Y. 2002. The potential for an interaction
between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate
inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet
17: 23-33.
379. Naruhashi K, Tamai I, Inoue N, Muraoka Hm Sai Y, Suzuki N, Tsuji A. 2002. Involvement
of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.
Antimicrob Agents Chemother 46: 344-349.
380. Huisman MT, Smit JW, Crommentuyn KM, Zelcer N, Wiltshire HR, Beijnen JH, Schinkel
AH. 2002. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and
transport can be enhanced by other drugs. AIDS 16: 2295-2301.
381. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, Lieberman MW. 2000.
The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required
for biliary excretion of arsenic. J Biol Chem 275: 33404-33408.
382. Dietrich CG, de Waart DR, Ottenhoff R, Bootsma AH, Van Gennip AH, Oude Elferink
RPJ. 2001. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influ-
ences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-
phenylimidazo[4,5- b ]pyridine. Carcinogenesis 22: 805-811.
383. Dietrich CG, de Waart DR, Ottenhoff R, Schoots IG, Oude Elferink RPJ. 2001. Increased
bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-
b ]pyridine in MRP2-deficient rats. Mol Pharmacol 59: 974-980.
384. Leier I, Hummel-Eisenbeiss J, Cui Y, Keppler D. 2000. ATP-dependent para -
aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 57:
1636-1642.
385. van Aubel RA, van Kuijck MA, Koenderink JB, Deen PM, van Os CH, Russel FG.
1998. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit
multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol Pharmacol
53: 1062-1067.
386. Chen ZS, Furukawa T, Sumizawa T, Ono K, Ueda K, Seto K, Akiyama SI. 1999. ATP-
Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and
its inhibition by PAK-104P. Mol Pharmacol 55: 921-928.
387. Chen ZS, Kawabe T, Ono M, Aoki S, Sumizawa T, Furukawa T, Uchiumi T, Wada
M, Kuwano M, Akiyama SI. 1999. Effect of multidrug resistance-reversing agents on
transporting activity of human canalicular multispecific organic anion transporter. Mol
Pharmacol 56: 1219-1228.